Vitreous growth hormone and visual dysfunction

Neuroscience Letters

Volumn 460, Issue 1, 2009, Pages 87-91

  Ziaei, Misagh ^a   Tennant, Matthew ^b   Sanders, Esmond J ^a   Harvey, Steve ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b ROYAL ALEXANDRA HOSPITAL   (Canada)

Author keywords

Growth hormone; Human; Retina; Vitreous

Indexed keywords

GROWTH HORMONE;

ADULT; AGED; ARTICLE; CADAVER; CENTRAL RETINA VEIN OCCLUSION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIRETINAL MEMBRANE; EYE DISEASE; FEMALE; HUMAN; IMMUNOREACTIVITY; INSULIN DEPENDENT DIABETES MELLITUS; LENS LUXATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PRIORITY JOURNAL; RETINA DEGENERATION; RETINA DETACHMENT; RETINA HEMORRHAGE; RETINA MACULA HOLE; VISUAL DISORDER; VITREOUS BODY; VITREOUS HEMORRHAGE;

ADULT; AGED; AGED, 80 AND OVER; DIABETES COMPLICATIONS; DIABETES MELLITUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GROWTH HORMONE; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; PROTEINS; VISION DISORDERS; VITREOUS BODY; YOUNG ADULT;

EID: 67349092104     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.05.048     Document Type: Article

References (49)

1. Ahmad T., Garcia-Filion P., Borchert M., Kaufman F., Burkett L., and Geffner M. Endocrinological and auxological abnormalities in young children with optic nerve hypoplasia: a prospective study. J. Pediatr. 148 (2006) 78-84
2. Aguila M.C., and McCann S.M. Growth hormone increases somatostatin release and messenger ribonucleic acid levels in the rat hypothalamus. Brain Res. 623 (1993) 89-94
3. Baudet M.-L., Sanders E.J., and Harvey S. Retinal growth hormone in the chick embryo. Endocrinology 144 (2003) 5459-5468
4. Baudouin C., Fredj-Reygrobellet D., Brignole F., Negre F., Lapalus P., and Gastaud P. Growth factors in vitreous and subretinal fluid cells from patients with proliferative vitreoretinopathy. Ophthalmic Res. 25 (1993) 52-59
5. Beharry K.D., Modanlou H.D., Hasan J., Gharraee Z., Abad-Santos P., Sills J.H., Jan A., Nageotte S., and Aranda J.V. Comparative effects of early postnatal ibuprofen and indomethacin on VEGF, IGF-1, and GH during rat ocular development. Invest. Ophthalmol. Vis. Sci. 47 (2006) 3036-3043
6. Boehm B.O. Use of long-acting somatostatin analogue treatment in diabetic retinopathy. Dev. Ophthalmol. 39 (2007) 111-121
7. Boulton M., Gregor Z., McLeod D., Charteris D., Jarvis-Evans J., Moriarty P., Khaliq A., Foreman D., Allamby D., and Bardsley B. Intravitreal growth factors in proliferative diabetic retinopathy: correlation with neovascular activity and glycaemic management. Brit. J. Ophthalmol. 81 (1997) 228-233
8. Burgos R., Mateo C., Canton A., Hernandez C., Mesa J., and Simo R. Vitreous levels of IGF-I, IGF binding protein 1, and IGF binding protein 3 in proliferative diabetic retinopathy: a case-control study. Diabetes Care 23 (2000) 80-83
9. Carrasco E., Hernandez C., Miralles A., Huguet P., Farres J., and Simo R. Lower somatostatin expression is an early event in diabetic retinopathy and is associated with retinal neurodegeneration. Diabetes Care 30 (2007) 2902-2908
10. Cunha-Vaz J.G. Blood-retinal barriers in health and disease. Trans. Ophthalmol. Soc. UK 100 (1980) 337-340
11. Cunha-Vaz J.G. The blood retinal barriers system. Basic concepts and clinical evaluation. Exp. Eye Res. 78 (2004) 715-721
12. Frystyk J. The growth hormone hypothesis - 2005 revision. Horm. Metab. Res. 37 (2005) 44-48
13. Giordano R., Lanfranco F., Bo M., Pellegrino M., Picu A., Baldi M., Balbo M., Bonelli L., Grottoli S., Ghigo E., and Arvat E. Somatopause reflects age-related changes in the neural control of GH/IGF-I axis. J. Endocrinol. Invest. 28 (2005) 94-98
14. Guidry C., Feist R., Morris R., and Hardwick C.W. Changes in IGF activities in human diabetic vitreous. Diabetes 53 (2004) 2428-2435
15. Harvey S., Baudet M.-L., and Sanders E.J. Retinal growth hormone in perinatal and adult rats. J. Mol. Neurosci. 28 (2006) 257-264
16. Harvey S., Kakebeeke M., Murphy A.E., and Sanders E.J. Growth hormone in the nervous system: autocrine or paracrine roles in retinal function?. Can. J. Physiol. Pharm. 81 (2003) 371-394
17. Harvey S., Baudet M.-L., and Sanders E.J. Growth hormone and developmental ocular function: clinical and basic studies. Pediatr. Endocrinol. Rev. 5 (2007) 510-515
18. Harvey S., Martin B.T., Baudet M.-L., Davis P., Sauve Y., and Sanders E.J. Growth hormone in the visual system: comparative endocrinology. Gen. Comp. Endocrinol. 153 (2007) 124-131
19. Harvey S., Parker E., Macdonald I., and Sanders E.J. Growth hormone is present in the human retina and vitreous fluid. Neurosci. Lett. 455 (2009) 199-202
20. Hellstorm A., Svensson E., Carlsson B., Niklasson A., and Albertsson-Wikland K. Reduced retinal vascularization in children with growth hormone deficiency. J. Clin. Endocrinol. Metab. 84 (1999) 795-798
21. Harobe M. A method for determination of hemoglobin in plasma by near-ultraviolet spectrophostometry. Scand. J. Clin. Lab. Invest. 11 (1959) 66-70
22. Inokuchi N., Ikeda T., Imamura Y., Sotozono C., Kinoshita S., Uchihori Y., and Nakamura K. Vitreous levels of insulin-like growth factor-1 in patients with proliferative diabetic retinopathy. Curr. Eye Res. 23 (2001) 368-371
23. Ishihara M. Optic hypoplasia with pituitary dwarfism (Kaplan-Grumbach-Hoyt syndrome, or DeMorsier Syndrome). Endocrinol. Japon. 30 (1983) 7-14
24. James C.R., and Cotlier E. Fate of insulin in the retina: an autoradiographic study. Brit. J. Ophthalmol. 67 (1983) 80-88
25. Kanamori A., Nakamura M., Mukuno H., Maeda H., and Negi A. Diabetes has an additive effect on neural apoptosis in rat retina with chronically elevated intraocular pressure. Curr. Eye Res. 28 (2004) 47-54
26. Martin F.C., Yeo A.L., and Sonksen P.H. Growth hormone secretion in the elderly: ageing and the somatopause. Bailliere Clin. Endocrinol. Metab. 11 (1997) 223-250
27. Modanlou H.D., Gharraee Z., Hasan J., Waltzman J., Nageotte S., and Beharry K.D. Ontogeny of VEGF, IGF-1, and GH in neonatal rat serum, vitreous fluid, and retina from birth to weaning. Invest. Ophthalmol. Vis. Sci. 47 (2006) 738-744
28. Nakamura M., Kanamori A., and Negi A. Diabetes mellitus as a risk factor for glaucomatous optic neuropathy. Ophthalmologica 219 (2005) 1-10
29. Nardelli G.M., Guastamacchia E., Di Paolo S., Balice A., Rosco M., Santoro G., Lollino G., and Giorgino R. Somatomedin-C (SM-C). Study in diabetic patients with and without retinopathy. Acta Diabetol. Lat. 26 (1989) 217-224
30. Ogino Y., Toriumi M., and Tanaka K. Endocrine disorders associated with impaired glucose tolerance. Nippon Rinsho 54 (1996) 2667-2671
31. Oshitari T., and Roy S. Diabetes: a potential enhancer of retinal injury in rat retinas. Neurosci. Lett. 390 (2005) 25-30
32. Otteson D.C., Cirenza P.F., and Hitchcock P.F. Persistent neurogenesis in the teleost retina: evidence for regulation by the growth-hormone/insulin-like growth factor-1 axis. Mech. Dev. 117 (2002) 137-149
33. Pfeiffer A., Spranger J., Meyer-Schwickerath R., and Schatz H. Growth factor alterations in advanced diabetic retinopathy: a possible role of blood retina barrier breakdown. Diabetes 46 (1997) S26-S30
34. Plewe G., Noelken G., Drause U., Beyer J., and del Pozo E. Suppression of growth hormone and somatomedin C by long-acting somatostatin analog SMS 201-995 in type I diabetes mellitus. Horm. Res. 27 (1987) 7-12
35. Rymaszewski Z., Cohen R.M., and Chomczynski P. Human growth hormone stimulates proliferation of human retinal microvascular endothelial cells in vitro. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 617-621
36. Sanders E.J., and Harvey S. Growth hormone as an early embryonic growth and differentiation factor. Anat. Embryol. (Berl.) 209 (2004) 1-9
37. Sanders E.J., Parker E., Aramburo C., and Harvey S. Retinal growth hormone is an anti-apoptotic factor in embryonic retinal ganglion cell differentiation. Exp. Eye Res. 81 (2005) 551-560
38. Sanders E.J., Parker E., and Harvey S. Retinal ganglion cell survival in development: mechanisms of retinal growth hormone action. Exp. Eye Res. 83 (2006) 1205-1214
39. Sanders E.J., Parker E., and Harvey S. Endogenous GH in human retinal ganglion cells correlates with cell survival. Mol. Vision. 15 (2009) 920-926
40. Simo R., Hernandez C., Segura R.M., Garcia-Arumi J., Sararols L., Burgos R., Canton A., and Mesa J. Free insulin-like growth factor 1 in the vitreous fluid of diabetic patients with proliferative diabetic retinopathy: a case-control study. Clin. Sci. (Lond.) 104 (2003) 223-230
41. Simo R., Lecube A., Segura R.M., Garcia Arumi J., and Hernandez C. Free insulin growth factor-1 and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy. Am. J. Ophthalmol. 134 (2002) 376-382
42. Simo R., Lecube A., Segura R.M., Garcia Arumi J., and Hernandez C. Deficit of somatostatin-like immunoreactivity in the vitreous fluid of diabetic patients: possible role in the development of proliferative diabetic retinopathy. Diabetes Care 25 (2002) 2282-2286
43. Sjolie A.K., and Moller F. Medical management of diabetic retinopathy. Diabet. Med. 21 (2004) 666-672
44. Spranger J., Buhnen J., Jansen V., Krieg M., Meyer-Schwickerath R., Blum W.F., Schatz H., and Pfeiffer A.F. Systemic levels contribute significantly to increased intraocular IGF-I, IGF-II, and IGF-BP3 [correction of IFG-BP3] in proliferative diabetic retinopathy. Horm. Metab. Res. 32 (2000) 196-200
45. Spranger J., Mohlig M., Osterhoff M., Buhnen J., Blum W.F., and Pfeiffer A.F. Retinal photocoagulation does not influence intraocular levels of IGF-I, IGF-II and IGF-BP3 in proliferative diabetic retinopathy-evidence for combined treatment of PDR with somatostatin analogues and retinal photocoagulation?. Horm. Metab. Res. 33 (2001) 312-316
46. Smith L.E., Kopchick J.J., Chen W., Knapp J., Kinose F., Daley D., Foley E., Smith R.G., and Schaeffer J.M. Essential role of growth hormone in ischemia-induced retinal neovascularization. Science 276 (1997) 1706-1709
47. Wilkinson-Berka J.L., Wraight C., and Werther G. The role of growth hormone, insulin-like growth factor and somatostatin in diabetic retinopathy. Curr. Med. Chem. 13 (2006) 3307-3317
48. Wilkinson-Berka J.L., Lofthouse S., Jaworski K., Ninkovic S., Tachas G., and Wraight C.J. An antisense oligonucleotide targeting the growth hormone receptor inhibits neovascularization in a mouse model of retinopathy. Mol. Vis. 13 (2007) 1529-1538
49. Yukizane S., Kimura Y., Yamashita Y., Matsuishi T., Horikawa H., Ando H., and Yamashita F. Growth hormone deficiency of hypothalamic origin in septo-optic dysplasia. Eur. J. Pediatr. 150 (1990) 30-33